首頁 > 市場調查報告書 > 製藥

醫藥品法規環境

市場調查報告書

商品編碼

1529572

藥物安全檢測市場：依臨床試驗階段、依方法類型、依服務供應商類型、按地區

Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography

出版日期: 2024年06月27日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球藥物安全檢測市場規模為74.1億美元，2031年將達128億美元，2024年至2031年複合年成長率為8.1%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	74.1億美元
實際資料	2019-2023	預測期	2024-2031
2024-2031 年預測期複合年成長率	8.10%	2031 年金額預測	128億美元

圖：2024 年按地區分類的藥物安全檢測市場佔有率(%)

近年來，全球藥物安全檢測市場經歷了顯著成長。藥物安全檢測被定義為與檢測、評估、理解和預防副作用和其他藥物相關問題相關的科學和活動。隨著藥物分子變得更加複雜，新的治療方法不斷推向市場，上市後有效監測藥物安全性的需求也隨之增加。強制進行藥物安全監測的嚴格法律規範以及副作用的增加正在推動全球對藥物安全檢測服務的需求。此外，學名藥市場的擴張以及臨床試驗向新興地區的外包也進一步推動了藥物安全檢測市場的發展。

市場動態：

全球藥物安全檢測市場的推動因素包括藥物副作用發生率的增加、藥物核准的嚴格安全法規、對有效治療方法的需求不斷增加以及學名藥市場的擴大。強制進行上市後監督的嚴格監管指南是推動藥物安全檢測服務需求的主要因素。此外，由於安全問題而導致的藥品召回趨勢不斷成長，迫使藥廠將藥物安全檢測業務委託給專業服務供應商。此外，已開發國家學名藥市場的擴張為藥物安全檢測市場的參與企業提供了重大機會。然而，中小型製藥企業的預算限制以及跨地區報告藥品安全資料的複雜性給市場參與企業帶來了挑戰。

本研究的主要特點

該報告詳細分析了全球藥物安全檢測市場，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球藥物安全檢測市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球藥物安全檢測市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於全球藥物安全檢測市場分析的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Accenture
- Cognizant Technology Solutions
- Laboratory Corporation of America Holdings（LabCorp）
- IBM Corporation
- QuintilesIMS（IQVIA）
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation（UBC）
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Inc

第10章分析師建議

上升和下降
綜合機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1047

The global pharmacovigilance market is estimated to be valued at USD 7.41 Bn in 2024 and is expected to reach USD 12.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 7.41 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.10%	2031 Value Projection:	US$ 12.80 Bn

Figure. Pharmacovigilance Market Share (%), By Region 2024

The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.

Market Dynamics:

The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.

Key Features of the Study:

This report provides in-depth analysis of the global pharmacovigilance market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market

Detailed Segmentation-

By Clinical Trial Phases
- Total Knee Replacement
- Partial Knee Replacement
- Kneecap Replacement
- Revision Knee Replacement
By Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
By Type of Service Provider
- In-House
- Contract Outsourcing
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Accenture
- Cognizant Technology Solutions
- Laboratory Corporation of America Holdings (LabCorp)
- IBM Corporation
- QuintilesIMS (IQVIA)
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation (UBC)
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Incc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Clinical Trial Phases
- Market Snapshot, By Type of Method
- Market Snapshot, By Type of Service Provider
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Pharmacovigilance Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Pharmacovigilance Market, By Clinical Trial Phases, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pre-clinical Studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Trial Phase I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Trial Phase II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Trial Phase III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Post Marketing Surveillance or Phase IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pharmacovigilance Market, By Type of Method, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Spontaneous Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intensified ADR Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Targeted Reporting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cohort Event Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
EHR Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pharmacovigilance Market, By Type of Service Provider, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
In-House
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Contract Outsourcing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Pharmacovigilance Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Accenture
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cognizant Technology Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Laboratory Corporation of America Holdings (LabCorp)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- IBM Corporation
- QuintilesIMS (IQVIA)
- ICON plc
- Capgemini
- ITClinical
- TAKE Solutions Ltd
- BioClinica
- PAREXEL International Corporation
- Wipro Ltd
- FMD K&L
- Linical Accelovance
- United BioSource Corporation (UBC)
- PRA Health Sciences
- ArisGlobal
- Ennov Solutions Inc